Senores Pharmaceuticals Limited - Company Profile

It is a pharma public limited company based in Ahmedabad, Gujarat, India, established in 2017.
2017 Ahmedabad, Gujarat, India Active
Last Updated:
Access Report
About Senores Pharmaceuticals Limited

Senores Pharmaceuticals Limited, a active public limited company, was established on 26 December 2017 in Ahmedabad, Gujarat, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: L24290GJ2017PLC100263. Registered under ROC Roc Ahmedabad. it is listed. It has an authorized capital of ₹59.00 Cr and a paid-up capital of ₹46.05 Cr.

It upholds a compliant status. In 2024, it reported revenue of ₹40.85 Cr and a net worth of ₹168.12 Cr. Employing 120 professional, Its leadership includes Sanjay Shaileshbhai Majmudar (Director), Ashokbhai Vijaysinh Barot (Director), Swapnil Jatinbhai Shah (Managing Director). Past directors included Sanjay Shaileshbhai Majmudar, Ashokbhai Vijaysinh Barot, Sangeeta Mukur Barot. It holds ₹115.14 Cr open charges and ₹130.75 Cr settled loans. Its latest AGM occurred on 18 September 2025, with the balance sheet filed on 31 March 2025. It is based at 1101 To 1103, 11Th Floor, South Tower, One 42 Opp. Jayantilal Park, Ambali Bopal Road,, Ahmedabad, Gujarat, 380054.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    L24290GJ2017PLC100263

  • Registration Number

    100263

  • Incorporation Date

    26 December 2017

  • Authorized Capital

    ₹59.00 Cr

  • Paid-Up Capital

    ₹46.05 Cr

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Listed

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 59.00 Cr
  • Paid Up Capital ₹ 46.05 Cr
  • Company Age 8 Year, 1 Month
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 115.14 Cr
  • Satisfied Charges ₹ 130.75 Cr
  • Revenue Growth **** 133.24%
  • Profit Growth **** -55.57%
  • Ebitda **** 96.52%
  • Net Worth 340.17%
  • Total Assets **** 178.54%
Company report

Senores Pharmaceuticals Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Senores Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Senores Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Sanjay Shaileshbhai Majmudar Director 10 Feb 2024 Current
Ashokbhai Vijaysinh Barot Director 15 May 2018 Current
Swapnil Jatinbhai Shah Managing Director 15 Oct 2021 Current
Naresh Bansilal Shah Director 30 Jan 2024 Current
Hemanshu Nitinchandra Pandya Director 10 Nov 2023 Current
Chetan Bipinchandra Shah Whole-Time Director 10 Nov 2023 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 18 Feb 2024 Past
Pramod Abcsdd Additional Director 30 Sep 2018 Past
Pramod Abcsdd Additional Director 30 Sep 2018 Past
Pramod Abcsdd Additional Director 23 Nov 2021 Past
Pramod Abcsdd Director 11 Oct 2021 Past
Pramod Abcsdd Director 01 Jun 2021 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Senores Pharmaceuticals.

Senores Pharmaceuticals Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 133.24% increase. The company also saw a substantial fall in profitability, with a 55.57% decrease in profit. The company's net worth Soared by an impressive increase of 340.17%.

Senores Pharmaceuticals revenue growth over time
Senores Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 133.24%
*******
*******
*******
*******
Revenue from Operations
*******
 226.86%
*******
*******
*******
*******
Total Assets
*******
 178.54%
*******
*******
*******
*******
Profit or Loss
*******
 -55.57%
*******
*******
*******
*******
Net Worth
*******
 340.17%
*******
*******
*******
*******
EBITDA
*******
 96.52%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Senores Pharmaceuticals?

In 2024, Senores Pharmaceuticals had a promoter holding of 71.35% and a public holding of 28.66%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹1,151,399,080.00

Satisfied Charges

₹1,307,500,000.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 65.14 Cr
  • Others : 50.00 Cr
Latest Charge Details
Date Lender Amount Status
13 Nov 2025 Hdfc Bank Limited ₹2.30 M Open
26 Jun 2025 Hdfc Bank Limited ₹4.46 M Open
02 May 2025 Hdfc Bank Limited ₹3.51 M Open
13 Feb 2025 Others ₹45.00 Cr Open
07 Dec 2024 Hdfc Bank Limited ₹1.13 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Senores Pharmaceuticals?

Senores Pharmaceuticals has a workforce of 120 employees as of Feb 10, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Senores Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Senores Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Senores Pharmaceuticals
Recent Activity within the Organization
  • Charges

    The activity A charge with Hdfc Bank Limited amounted to Rs. 0.23 Cr with Charge ID 101189074 was registered on 13 Nov 2025. was completed.

  • Annual General Meeting

    Progress on Senores Pharmaceuticals Limited last Annual general meeting of members was held on 18 Sep 2025 as per latest MCA records. was documented.

  • Charges

    A charge with Hdfc Bank Limited of Rs. 64.00 Cr registered on 31 Dec 2022 with Charge ID 100668335 was modified on 31 Jul 2025. was recorded as a recent event.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 0.45 Cr with Charge ID 101113826 was registered on 26 Jun 2025. was recorded as a recent event.

  • Charges

    Progress on A charge with Hdfc Bank Limited amounted to Rs. 0.35 Cr with Charge ID 101087233 was registered on 02 May 2025. was documented.

  • Balance Sheet

    Senores Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Senores Pharmaceuticals Limited?

The CIN of Senores Pharmaceuticals Limited is L24290GJ2017PLC100263.

Where is Senores Pharmaceuticals Limited headquartered?

Senores Pharmaceuticals Limited is headquartered at 1101 To 1103, 11Th Floor, South Tower, One 42 Opp. Jayantilal Park, Ambali Bopal Road,, Ahmedabad, Gujarat, 380054.

When was Senores Pharmaceuticals Limited incorporated?

Senores Pharmaceuticals Limited was incorporated on 26 December 2017.

Who are the current directors of Senores Pharmaceuticals Limited?

The current directors of Senores Pharmaceuticals Limited are

What is the primary industry of Senores Pharmaceuticals Limited?

The primary industry of Senores Pharmaceuticals Limited is Manufacturing.

Is Senores Pharmaceuticals Limited a listed company?

Senores Pharmaceuticals Limited is listed.

What is the capital structure of Senores Pharmaceuticals Limited?

The authorized capital of Senores Pharmaceuticals Limited is ₹59.00 Cr, and the paid-up capital is ₹46.05 Cr.

What is the compliance status of Senores Pharmaceuticals Limited?

The compliance status of Senores Pharmaceuticals Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available